27357530|t|Bone - Albumin filling decreases donor site morbidity and enhances bone formation after anterior cruciate ligament reconstruction with bone-patellar tendon-bone autografts
27357530|a|Donor site pain affects 32-43 % of patients after anterior cruciate ligament surgery when the autograft is freshly harvested bone-patellar tendon-bone tissue. Our aim was to compare functional and morphological differences between donor sites with and without serum albumin - coated bone allograft filling. After harvesting and implanting the graft, the tibia site was filled with either fresh autologous cancellous bone enhanced with albumin - coated allograft or autologous bone alone. The patella site was filled either with albumin - coated allograft or with blood clot. Knee function was evaluated by the VISA, Lysholm and IKDC scores and a visual analog scale of pain during standing, kneeling and crouching after six weeks and six months. Computed tomography was performed at six months for morphological evaluation. At six weeks, both groups were still recovering from surgery and the overall knee function was still impaired but the functional scores were significantly higher in the Bone - Albumin group. The pain with crouching and kneeling was also lower as compared to controls. At six months, the knee function scores were close to normal, with a slight decrease in the controls. Pain at kneeling was still prominent in the controls, but significantly lower in the Bone - Albumin group. Computed tomography showed significantly smaller bone defects and higher bone density in the Bone - Albumin group. Results from the present study indicate that donor site pain, a disturbing long-term side effect of bone-patellar tendon-bone surgery, is significantly reduced if bone buildup in the patella and the tibia is augmented by serum albumin - coated bone allografts.
27357530	0	4	Bone	T023	C0262950
27357530	7	14	Albumin	T116,T123	C0001924
27357530	15	22	filling	T061	C0087111
27357530	23	32	decreases	T081	C0547047
27357530	33	43	donor site	T029	C1444716
27357530	44	53	morbidity	T081	C0026538
27357530	58	66	enhances	T052	C2349975
27357530	67	81	bone formation	T042	C0029433
27357530	88	114	anterior cruciate ligament	T023	C0078960
27357530	115	129	reconstruction	T061	C0524865
27357530	135	160	bone-patellar tendon-bone	T024	C3658331
27357530	161	171	autografts	T122	C0559189
27357530	172	182	Donor site	T029	C1444716
27357530	183	187	pain	T184	C0030193
27357530	207	215	patients	T101	C0030705
27357530	222	248	anterior cruciate ligament	T023	C0078960
27357530	249	256	surgery	T091	C0038894
27357530	266	275	autograft	T122	C0559189
27357530	279	286	freshly	T080	C0443224
27357530	287	296	harvested	T058	C1512335
27357530	297	329	bone-patellar tendon-bone tissue	T024	C3658331
27357530	346	353	compare	T052	C1707455
27357530	354	364	functional	T169	C0205245
27357530	369	382	morphological	T082	C0543482
27357530	383	394	differences	T080	C1705242
27357530	403	414	donor sites	T029	C1444716
27357530	432	445	serum albumin	T116	C0036773
27357530	448	454	coated	T080	C1522408
27357530	455	459	bone	T023	C0262950
27357530	460	469	allograft	T122	C0450127
27357530	470	477	filling	T061	C0087111
27357530	485	495	harvesting	T058	C1512335
27357530	500	510	implanting	T061	C0021107
27357530	515	520	graft	T122	C0181074
27357530	526	531	tibia	T023	C0040184
27357530	532	536	site	T029	C1515974
27357530	560	565	fresh	T080	C0443224
27357530	566	576	autologous	T080	C0439859
27357530	577	592	cancellous bone	T024	C0222660
27357530	593	601	enhanced	T052	C2349975
27357530	607	614	albumin	T116,T123	C0001924
27357530	617	623	coated	T080	C1522408
27357530	624	633	allograft	T122	C0450127
27357530	637	647	autologous	T080	C0439859
27357530	648	652	bone	T023	C0262950
27357530	664	671	patella	T023	C0030647
27357530	672	676	site	T029	C1515974
27357530	700	707	albumin	T116,T123	C0001924
27357530	710	716	coated	T080	C1522408
27357530	710	716	coated	T080	C1522408
27357530	717	726	allograft	T122	C0450127
27357530	735	745	blood clot	T046	C0302148
27357530	747	751	Knee	T023	C0022742
27357530	752	760	function	T039	C0031843
27357530	765	774	evaluated	T058	C0220825
27357530	782	786	VISA	T201	C2960738
27357530	788	795	Lysholm	T170	C2200320
27357530	800	811	IKDC scores	T081	C0449820
27357530	818	845	visual analog scale of pain	T060	C0042815
27357530	853	861	standing	T082	C0231472
27357530	863	871	kneeling	T033	C1260920
27357530	876	885	crouching	T033	C0560489
27357530	896	901	weeks	T079	C0439230
27357530	910	916	months	T079	C0439231
27357530	918	937	Computed tomography	T060	C0040405
27357530	959	965	months	T079	C0439231
27357530	970	983	morphological	T082	C0543482
27357530	984	994	evaluation	T058	C0220825
27357530	1003	1008	weeks	T079	C0439230
27357530	1015	1021	groups	T078	C0441833
27357530	1033	1048	recovering from	T080	C0521108
27357530	1049	1056	surgery	T091	C0038894
27357530	1065	1072	overall	T080	C1561607
27357530	1073	1077	knee	T023	C0022742
27357530	1078	1086	function	T039	C0031843
27357530	1097	1105	impaired	T169	C0221099
27357530	1114	1124	functional	T169	C0205245
27357530	1125	1131	scores	T081	C0449820
27357530	1137	1157	significantly higher	T081	C4055637
27357530	1165	1169	Bone	T023	C0262950
27357530	1172	1179	Albumin	T116,T123	C0001924
27357530	1180	1185	group	T078	C0441833
27357530	1191	1195	pain	T184	C0030193
27357530	1201	1210	crouching	T033	C0560489
27357530	1215	1223	kneeling	T033	C1260920
27357530	1233	1238	lower	T052	C2003888
27357530	1242	1250	compared	T052	C1707455
27357530	1254	1262	controls	T096	C0009932
27357530	1271	1277	months	T079	C0439231
27357530	1283	1287	knee	T023	C0022742
27357530	1288	1296	function	T039	C0031843
27357530	1297	1303	scores	T081	C0449820
27357530	1318	1324	normal	T080	C0205307
27357530	1340	1348	decrease	T081	C0547047
27357530	1356	1364	controls	T096	C0009932
27357530	1366	1370	Pain	T184	C0030193
27357530	1374	1382	kneeling	T033	C1260920
27357530	1393	1402	prominent	T080	C0205402
27357530	1410	1418	controls	T096	C0009932
27357530	1424	1443	significantly lower	T081	C4055638
27357530	1451	1455	Bone	T023	C0262950
27357530	1458	1465	Albumin	T116,T123	C0001924
27357530	1466	1471	group	T078	C0441833
27357530	1473	1492	Computed tomography	T060	C0040405
27357530	1500	1513	significantly	T078	C0750502
27357530	1514	1521	smaller	T080	C0547044
27357530	1522	1526	bone	T023	C0262950
27357530	1527	1534	defects	T169	C1457869
27357530	1539	1545	higher	T080	C0205250
27357530	1546	1558	bone density	T201	C0005938
27357530	1566	1570	Bone	T023	C0262950
27357530	1573	1580	Albumin	T116,T123	C0001924
27357530	1581	1586	group	T078	C0441833
27357530	1588	1595	Results	T034	C0456984
27357530	1613	1618	study	T062	C0008972
27357530	1619	1627	indicate	T078	C0392360
27357530	1633	1643	donor site	T029	C1444716
27357530	1644	1648	pain	T184	C0030193
27357530	1663	1672	long-term	T079	C0443252
27357530	1673	1684	side effect	T046	C0879626
27357530	1688	1713	bone-patellar tendon-bone	T024	C3658331
27357530	1714	1721	surgery	T091	C0038894
27357530	1726	1739	significantly	T078	C0750502
27357530	1740	1747	reduced	T080	C0392756
27357530	1751	1755	bone	T023	C0262950
27357530	1771	1778	patella	T023	C0030647
27357530	1787	1792	tibia	T023	C0040184
27357530	1809	1822	serum albumin	T116	C0036773
27357530	1825	1831	coated	T080	C1522408
27357530	1832	1836	bone	T023	C0262950
27357530	1837	1847	allografts	T122	C0450127